March 18, 2022
Patient Experiences: Disparate Sickle Cell Disease Treatment
In this MD Newsline exclusive interview with Krystal Preston, PharmD, we discuss her personal experiences with receiving disparate sickle cell disease treatment as a patient. We also discuss how health care professionals can rectify sickle cell disease disparities in care. MD Newsline: Have you personally experienced disparities in care as a patient with sickle cell...
Krystal Preston, PharmD: Providing Culturally Sensitive Care
In this MD Newsline exclusive interview with Krystal Preston, PharmD, we discuss how to provide culturally sensitive care and overcome language barriers. MD Newsline: How have you been able to implement culturally sensitive care in your work? Krystal Preston, PharmD: “Having experienced disparities in care as a patient, I’ve learned how to implement culturally sensitive...
Sickle Cell Disease Research: Improving Funding and Diversity
In this MD Newsline exclusive interview with Krystal Preston, PharmD, we discuss how to improve funding, diversity, and inclusion for sickle cell disease clinical trials. MD Newsline: Moving forward, how do you think we can increase funding for sickle cell disease clinical trials? Krystal Preston, PharmD: “Sickle cell disease is a disease that affects mainly...
How Far We’ve Come in Treating Sickle Cell Disease
In this MD Newsline exclusive interview with Krystal Preston, PharmD, we discuss the latest research on sickle cell disease treatment and how far we’ve come in treating sickle cell disease. MD Newsline: Is there any research that excites you or that you think is important for providers to know related to the treatment of sickle...
Pearls for Treating Patients With Sickle Cell Disease
In this MD Newsline exclusive interview with Krystal Preston, PharmD, we discuss her pearls for treating patients with sickle cell disease. We also discuss how to address pharmacist implicit bias. MD Newsline: Is there anything else you would like to speak on that we have not already covered? Krystal Preston, PharmD: “I just want to...
COVID-19 and Sickle Cell Disease Treatment Disparities
In this MD Newsline exclusive interview with Krystal Preston, PharmD, we discuss disparities in treating sickle cell disease before and during the COVID-19 pandemic. MD Newsline: What disparities in treating sickle cell disease have you observed as a clinical pharmacist? Krystal Preston, PharmD: “As a pharmacist as well as a patient living with sickle cell...
Individualized Care and Sickle Cell Disease
As one of the most commonly inherited disorders, sickle cell disease can warrant the need for specialized treatment plans. Especially when it comes to pain, different factors can arise and impact the daily lives of those with sickle cell disease. Therefore, there is a need for individualized care plans when treating acute pain crises from...
Opioids for Pediatric Sickle Cell Disease
Pain, along with swelling and fatigue, is one of the cornerstone symptoms of sickle cell disease. Children with sickle cell disease may often experience painful vaso-occlusive episodes, which require appropriate pain management. In most cases, adequate pain management consists of rehydration, rest, and analgesics. But where do opioids fit into this treatment strategy? Common analgesics...
Sickle Cell Disease and Gaps in Care
Barriers to proper treatment for sickle cell disease (SCD) depend not only on individual patient factors. Other factors involving healthcare provider knowledge on treating SCD and expertise can also hinder access to appropriate care. SCD is a rare disease that can lead to acute and chronic complications in patients. For this reason, optimal care is...